NVAX vs WFC · P/E 2.5, rev $196.2M vs P/E 15, rev $22.62B
Novavax Inc (NVAX) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
Novavax Inc (NVAX) is a biotechnology company listed on US.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported NVAX revenue for 2026-06-30 was $196.2M. Net income was -$62.9M. Revenue was up 40.6% from 2026-03-31 to 2026-06-30. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
Latest reported WFC revenue for 2026-06-30 was $22.62B. Net income was $6.41B. Revenue was up 5.5% from 2026-03-31 to 2026-06-30. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
NVAX currently screens at market cap $1.09B and trailing P/E 2.5. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the NVAX and WFC stock pages for the full models.
Not investment advice.